These results are consistent with a metabolic effect as 2-bromopalmitate inhibits a variety of enzymes, some of which are required for TAG formation, a process that has been shown to be critical for the survival of HER2/neu-positive breast cancer cells [6, 7, 42]. Here, ERBB2 is linked to breast cancer.